Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 6501 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Eyenovia, Inc.

Praluent® (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Travere Therapeutics Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy (IgAN)

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Travere Therapeutics, Inc.

Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities

Read more ››
By: GlobeNewswire - 11 Mar 2024
Related companies:  Lexicon Pharmaceuticals, Inc.

EcoCeres Appoints Matti Lievonen as Executive Chairman

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

AI Empowers Surgery: CAIR unveils its latest large multimodality model for surgery

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Upcoming 89th CMEF in Shanghai to Showcase Innovative Technological Advancements Spanning the Entire Value Chain of the Medical Equipment Industry

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Mallinckrodt plc

Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Compugen Ltd.

Apollo Hospitals Unveils South Asia's First ZAP-X, Transforming Brain Tumor Care

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Dr. Louis DeJoseph Is Named 2024 Top Doctor by Castle Connolly

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

2024 Summit Gala: In Unity We Flourish - Supporting Our Community

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

RedHill Announces New USPTO Patent Covering Talicia® Through 2034

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

Cepheid Receives FDA Clearance for Xpert® Xpress GBS

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Cepheid

NEXT for AUTISM Announces 2024 Grant Funding Cycle for Autistic-led and Community-based Organizations

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

REGENXBIO to Participate in Upcoming Investor Conferences

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  REGENXBIO Inc.

Arthritic Therapeutic Market to Reach $ 136.1 billion, Globally, by 2032 at 5.5% CAGR: Allied Market Research

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  BioArctic AB

ColdZyme® certified under the new EU medical device regulation (MDR)

Read more ››
By: PR Newswire Association LLC. - 11 Mar 2024
Related companies:  Enzymatica AB
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑